151 related articles for article (PubMed ID: 17303494)
1. Predictors of acceptability of medication abortion.
Teal SB; Dempsey-Fanning A; Westhoff C
Contraception; 2007 Mar; 75(3):224-9. PubMed ID: 17303494
[TBL] [Abstract][Full Text] [Related]
2. Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol.
Chen AY; Mottl-Santiago J; Vragovic O; Wasserman S; Borgatta L
Contraception; 2006 Apr; 73(4):415-9. PubMed ID: 16531178
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
Jensen JT; Harvey SM; Beckman LJ
Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
[TBL] [Abstract][Full Text] [Related]
4. Medication abortion.
Bartz D; Goldberg A
Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
[TBL] [Abstract][Full Text] [Related]
5. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
[TBL] [Abstract][Full Text] [Related]
6. Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study.
Rørbye C; Nørgaard M; Nilas L
Hum Reprod; 2005 Mar; 20(3):834-8. PubMed ID: 15618257
[TBL] [Abstract][Full Text] [Related]
7. One or two day mifepristone-misoprostol interval for second trimester abortion.
Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
[TBL] [Abstract][Full Text] [Related]
8. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
Arvidsson C; Hellborg M; Gemzell-Danielsson K
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
[TBL] [Abstract][Full Text] [Related]
9. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
Singh KC; Ummat S; Rajaram S; Goel N
Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):495-8. PubMed ID: 16401215
[TBL] [Abstract][Full Text] [Related]
10. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, acceptability and safety of medication abortion in low-income, urban Latina women.
Teal SB; Harken T; Sheeder J; Westhoff C
Contraception; 2009 Nov; 80(5):479-83. PubMed ID: 19835724
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
Li CL; Wei M; Fu MF; Li M
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
[TBL] [Abstract][Full Text] [Related]
13. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
Li L; Zhou Z; Huang L
Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331
[TBL] [Abstract][Full Text] [Related]
16. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
Verhulsdonk MT; Papatsonis DN; Heydanus R
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
[TBL] [Abstract][Full Text] [Related]
17. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
[TBL] [Abstract][Full Text] [Related]
19. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
[TBL] [Abstract][Full Text] [Related]
20. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
